References
- Ahmed AB, Koster A, Lance M, et al. Eouropean guidelines on perioperative venous thromboembolism prophylaxis: cardiovascularand thoracic surgery. Eur J Anaesthesiol. 2018;35(2):84–89. doi:10.1097/EJA.0000000000000708
- Afshari A, Ageno W, Ahmed A, et al. European guidelines on perioperative venous thromboembolism prophylaxis: executivesummary. Eur J Anaesthesiol. 2018;35(2):77–83. doi:10.1097/EJA.0000000000000729
- Yun JL, Li XY. [Research status of pathoepidemiology of venous thromboembolism]. Zhong Hua Lao Nian Xin Nao Xue Guan Bing Za Zhi. 2017;19(7):322–324. Chinese.
- Zhang W, Wang DY, Cui D, et al. [Autopsy analysis of 12 cases of type 2 diabetes mellitus complicated with pulmonary embolism]. Zhong Guo LIn Chuang Yi Sheng Za Zhi. 2015;6(6):42–44. Chinese.
- Shimi M, Allouche M, Ben Ahmed H, et al. Sudden death duo to pulmonary rmbolism in north Tunisia:37 cases study. Tunis Med. 2014;92(10):610–614.
- Konstantinides SV, Torbicki A, Agnelli G, et al. ESC Committee for Practice Guidelines (CPG). Guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J. 2014;35:3033–3069.
- Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999;353:1386–1389. doi:10.1016/S0140-6736(98)07534-5
- Donze J, Le Gal G, Fine MJ, et al. Prospective validation of the pulmonary embolism severity index. A clinical prognostic model for pulmonary embolism. Thromb Haemost. 2008;100:943–948. doi:10.1160/TH08-05-0285
- Karatas MB, Ipek G, Onuk T, et al. Assessment of prognostic value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with pulmonary embolism. Acta Cardiol Sin. 2016;32(3):313–320.
- Karsy M, Azab MA, Harper J, et al. Evaluation of a D-dimer protocol for detection of venous thromboembolism. World Neurosurg. 2020;133:e774–e783. doi:10.1016/j.wneu.2019.09.160
- Giuseppe L, Emmanuel JF, Martina M, et al. C-reactive protein and venous thromboembolism: causalor casual association? Clin Chem Lab Med. 2010;48(12):1693–1701.
- Tamaki H, Khasnis A. Venous thromboembolism in systemic autoimmune diseases: a narrative review with emphasis on primary systemic vasculitides. Vasc Med. 2015;20(4):369–376. doi:10.1177/1358863X15573838
- Asakura H. [Thrombosis in myeloproliferative neoplasms]. Rinsho Ketsueki. 2018;59(8):1034–1041. Japanese.
- Mukubo Y, Kawamata M. Perioperative hypercoagulability in patients with rheumatoid arthritis: sonoclot study. J Anesth. 2004;18(1):62–64. doi:10.1007/s00540-003-0206-4
- Esmon CT. Inflammation and thrombosis. J Thromb Haemost. 2003;1(7):1343–1348. doi:10.1046/j.1538-7836.2003.00261.x
- Zhang NN, Shi XP, Chen XW, et al. Association between inflammatory markers,hemostatic markers,and microvascular complications in 182 Chinese patients with type 2 diabetes mellitus. Science. 2015;46(3):214–220.
- Zhang ZN, Hao YS, Zhao YQ, et al. Infectious diseases and hematological abnormalities. Hematology. 2013:1440–1445.
- Yan M, Cheng X, Lu Y, et al. [Relationship between different levels of C-reactive protein and IL-6 and anemia in cancer patients]. Zhong Guo Ji Xu Yi Xue Jiao Yu. 2018;10(34):76–78. Chinese.
- Cheng Z, Yan M, Lu Y, et al. Expression of serum BMP6 and hepcidin in cancer-related anemia. Hematology. 2020;25(1):134–138. doi:10.1080/16078454.2020.1738098